临床诊断市场：按测试、按产品、按最终用户、按地区 - 规模、份额、展望、机会分析，2022-2028 年

临床诊断是根据患者的体征和症状、患者的病史和体格检查来识别疾病、状况或损伤的过程。 临床诊断也被证明可用于疾病的预防、检测和管理。 这些测试有助于检测和监测许多医疗状况，包括慢性、传染性和自身免疫性疾病，并用于分析药物疗法。

市场动态

慢性病和传染病的负担不断增加、临床诊断的利用率增加、老年人口不断增加、研究和开发不断增加、COVID-19 的全球爆发等都将推动全球临床诊断市场的增长。

例如，2020 年 9 月，美国国立卫生研究院 (NIH) 作为其快速加速诊断 (RADx) 计划的一部分，扩大规模以支持製造一套新的 COVID-19 测试技术, 9计划向该公司投资1.293亿美元。 此外，2020 年 3 月，在欧盟委员会的研究和创新框架 Horizo□□n 2020 的支持下，创新药物计划 (IMI) 宣布将向五个致力于创新其诊断组合的组织提供 7200 万欧元的资金。

这项研究的主要特点

• 本报告对全球临床诊断市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2028) 的市场规模和復合年增长率 (CAGR%)。.
• 它还阐明了各个细分市场的潜在创收机会，并描述了针对该市场的一系列有吸引力的投资建议。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 根据以下参数对全球临床诊断市场的主要参与者进行了概况分析，包括公司亮点、产品组合、主要亮点、绩效和战略。
• 本研究涵盖的主要公司包括 Thermo Fisher Scientific、Qiagen N.V、Hologic Inc.、Siemens Healthineers AG、BioMerieux SA、Abbott Laboratories、Bio-Rad Laboratories Inc.、F. Hoffmann-La Roche AG、Becton、 Dickinson and Company 和 Danaher Corporation (Beckman Coulter, Inc.) 等。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
• 《全球临床诊断市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球临床诊断市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按类型分类
  • 市场概况：按产品分类
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 全球传染病和慢性病负担日益加重
  • 高端分子诊断试剂的成本更高
  • COVID-19 爆发（全球大流行）
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球临床诊断市场 - 冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学特征
• 供应方和需求方分析
• 经济影响

第 5 章全球临床诊断市场：按类型，2017-2028

• 脂质组
• 肝板
• 肾臟面板
• 全血细胞计数
• 电解质测试
• 传染病检测
• 其他测试

第 6 章全球临床诊断市场：按产品分类，2017-2028

• 检验设备
• 试剂
• 其他产品

第 7 章全球临床诊断市场：按最终用户分类，2017-2028

• 医院检查室
• 诊断实验室
• 即时检测
• 其他最终用户

第 8 章按地区分列的全球临床诊断市场，2017-2028

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地方

第9章竞争格局

• Thermo Fisher Scientific
• F. Hoffmann-La Roche AG
• Qiagen N.V
• Hologic Inc.
• Siemens Healthineers AG
• BioMerieux SA
• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Becton, Dickinson and Company
• Danaher Corporation（Beckman Coulter, Inc.）

第 10 章

• 调查方法介绍
• 关于出版商

Clinical diagnostic is the process of identifying a disease, condition, or injury based on the signs & symptoms a patient is having and patient's health history and physical exam. Clinical diagnostics have been also found to be valuable for the prevention, detection, and management of the disease. These tests help detect and monitor many medical conditions, such as chronic diseases, infectious diseases, and autoimmune diseases that are being used to analyze drug therapies.

Market Dynamics:

Growing burden of chronic and infectious diseases, increase in use of clinical diagnostic, growing geriatric population, increase in research and development, and outbreak of COVID-19 worldwide are expected to drive growth of the global clinical diagnostic market.

For instance, in September 2020, the National Institutes of Health (NIH) planned to give a funding of US$ 129.3 million to 9 companies to scale-up manufacturing support for a new set of COVID-19 testing technologies as part of Rapid Acceleration of Diagnostics (RADx) initiative. Moreover, in March 2020, Innovative Medicines Initiative (IMI), supported by the European Commission's Horizon 2020 Framework Programme for Research and Innovation, announced EUR 72 million funding to five organizations working to innovate diagnostic portfolios.

Key features of the study:

• This report provides in-depth analysis of the global clinical diagnostic market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global clinical diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Thermo Fisher Scientific, Qiagen N.V, Hologic Inc., Siemens Healthineers AG, BioMerieux SA, Abbott Laboratories, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, and Danaher Corporation (Beckman Coulter, Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global clinical diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical diagnostic market.

Detailed Segmentation:

• Global Clinical Diagnostic Market, By Test:
  • Lipid Panel
  • Liver Panel
  • Renal Panel
  • Complete Blood Count
  • Electrolyte Testing
  • Infectious Disease Testing
  • Other Tests
• Global Clinical Diagnostic Market, By Product:
  • Instruments
  • Reagents
  • Other Products
• Global Clinical Diagnostic Market, By End User:
  • Hospital Laboratory
  • Diagnostic Laboratory
  • Point-of-Care Testing
  • Other End Users
• Global Clinical Diagnostic Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Thermo Fisher Scientific
  • F.Hoffmann-La Roche AG
  • Qiagen N.V
  • Hologic Inc.
  • Siemens Healthineers AG
  • BioMerieux SA
  • Abbott Laboratories
  • Bio-Rad Laboratories Inc.
  • Becton, Dickinson and Company
  • Danaher Corporation (Beckman Coulter, Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Product
  • Market Snapshot, By End User
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing burden of infectious and chronic diseases worldwide
  • High cost of high-end molecular diagnostics
  • The outbreak of COVID-19 (global pandemic)
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Clinical Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Clinical Diagnostic Market, By Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Lipid Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Liver Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Renal Panel
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Complete Blood Count
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Electrolyte Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Infectious Disease Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Tests
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Clinical Diagnostic Market, By Product, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Instruments
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Products
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Clinical Diagnostic Market, By End User, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Hospital Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Diagnostic Laboratory
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Point-of-Care Testing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other End Users
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Clinical Diagnostic Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• F. Hoffmann-La Roche AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Qiagen N.V
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hologic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Siemens Healthineers AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BioMerieux SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bio-Rad Laboratories Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Becton, Dickinson and Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Danaher Corporation (Beckman Coulter, Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us